Literature DB >> 8259368

[Extensive pulmonary tumor embolisms of anaplastic thyroid gland carcinoma as a rare cause of hemorrhagic pleural effusion in an 88-year-old patient].

H Köppl1, E Scheer, E W Herbst.   

Abstract

An 88 year old woman without substantial previous illness was admitted to hospital because of a rapidly developing dyspnea and thoracic pains. X-Ray, CT scan and ultra sound showed a subdivided pleural effusion of the left side. After a short time a pulmonary infiltrate as well as a contralateral pleural effusion developed. Neither tumor cells nor mycobacteria could be detected in repeated pleural punctions. The general condition of the patient was deteriorating continuously while an antibiotic therapy given in the meantime only led to a temporary recovery. Three weeks later the patient died under the picture of a cardio-respiratory failure. At autopsy the lungs showed parenchymal haemorrhages and multiple infarctions as well as pleural effusions. The above mentioned changes could be explained histologically by tumor embolism of small pulmonary arteries from an anaplastic thyroid carcinoma. The discussion gives a short survey about already published cases of tumor embolism in the lung. PMVC as the diagnostic method of choice is discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8259368

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  3 in total

1.  Recurrent papillary thyroid carcinoma with pleural metastasis diagnosed by effusion cytology: a report of cases with clinicopathologic correlation.

Authors:  Reid I Sakamoto; Lauren C Sumida; Christopher A K Lum; Pamela S Tauchi-Nishi
Journal:  Hawaii J Med Public Health       Date:  2015-02

Review 2.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

3.  Pulmonary tumor embolism: A retrospective study over a 30-year period.

Authors:  Xin He; Douglas C Anthony; Zulmira Catoni; Weibiao Cao
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.